Skip to main content
. 2016 Jul 20;11(7):e0159485. doi: 10.1371/journal.pone.0159485

Table 1. Demographic data and clinical characteristics of the study population.

Variables Total(n = 1799) Age groups P
40-49(n = 584) 50-59(n = 615) 60-69(n = 414) ≥70(n = 186)
Male [n(%)] 726(40.4) 231(39.6) 240(39.0) 168(40.6) 87(46.8) 0.284
Formal Edu [n(%)] <0.001
Uneducated 228(12.7) 13(2.2) 38(6.2) 86(20.8) 91(48.9)
Primary school 518(28.8) 100(17.1) 133(21.6) 217(52.4) 68(36.6)
High school or above 1053(58.5) 471(80.7) 444(72.2) 111(26.8) 27(14.5)
Edu years [Median(P25, P75), y] 7(4,8) 8(7,9) 8(6,9) 4(2,7) 1(0,6) <0.001
Marital status [n(%)] <0.001
Married 1641(91.2) 567(97.1) 588(95.6) 361(87.2) 125(67.2)
Others 158(8.8) 17(2.9) 27(4.4) 53(12.8) 61(32.8)
Tobacco use [n(%)] 514(28.6) 169(28.9) 177(28.8) 114(27.5) 54(29) 0.962
Alcohol consumption [n(%)] 252(14.0) 91(15.6) 85(13.8) 51(12.3) 25(13.4) 0.522
Lack of physical activity [n(%)] 274(15.2) 59(10.1) 85(13.8) 64(15.5) 66(35.5) <0.001
Comorbidities [n(%)]
DM 220(12.2) 25(4.3) 75(12.2) 75(18.1) 45(24.2) <0.001
CHD 45(2.5) 2(0.3) 10(1.6) 15(3.6) 18(9.7) <0.001
Dyslipidemia 919(51.1) 254(43.5) 338(55.0) 220(53.1) 107(57.5) <0.001
Atrial fibrillation 11(0.6) 1(0.2) 2(0.3) 6(1.4) 2(1.1) -
TIA 31(1.7) 5(0.9) 9(1.5) 12(2.9) 5(2.7) 0.065
Family history [n(%)]
Stroke 353(19.6) 141(24.1) 130(21.1) 67(16.2) 15(8.1) <0.001
HP 557(31.0) 210(36.0) 202(32.8) 112(27.1) 33(17.7) <0.001
CHD 116(6.4) 44(7.5) 47(7.6) 20(4.8) 5(2.7) 0.030
DM 146(8.1) 67(11.5) 52(8.5) 19(4.6) 8(4.3) <0.001
Antihypertensive drugs [n(%)] 250(13.9) 28(4.8) 86(14.0) 93(22.5) 43(23.1) <0.001
Beta-blockers 8(0.4) 0(0) 2(0.3) 5(1.2) 1(0.5) -
Diuretics 46(2.6) 6(1.0) 19(3.1) 16(3.9) 5(2.7) -
CCB 63(3.5) 9(1.5) 28(4.6) 18(4.3) 8(4.3) 0.020
ACEI 64(3.6) 10(1.7) 25(4.1) 19(4.6) 10(5.4) 0.025
ARB 9(0.5) 2(0.3) 4(0.7) 3(0.7) 1(0.5) -
Others 104(5.8) 5(0.9) 30(4.9) 44(10.6) 25(13.4) <0.001
Physical examination [n(%)]
Cardiac murmur 30(1.7) 2(0.3) 11(1.8) 9(2.2) 8(4.3) -
Arrhythmia 43(2.4) 7(1.2) 12(2.0) 14(3.4) 10(5.4) -
SBP [Mean(SD), mmHg] 131.73(18.39) 124.25(15.04) 132.15(17.49) 136.41(18.76) 143.45(20.25) <0.001
SBP≥140 mmHg [n(%)] 680(37.8) 121(20.7) 242(39.3) 200(48.3) 117(62.9) <0.001
DBP [Mean(SD), mmHg] 81.90(10.17) 79.78(9.38) 82.91(10.32) 83.12(10.51) 82.48(10.34) <0.001
DBP≥90 mmHg [n(%)] 516(28.7) 121(20.7) 205(33.3) 140(33.8) 50(26.9) <0.001
MABP [Mean(SD), mmHg] 98.51(11.97) 94.60(10.63) 99.33(11.88) 100.88(12.27) 102.80(12.31) <0.001
MABP≥100 mmHg [n(%)] 773(43.0) 161(27.6) 286(46.5) 213(51.4) 113(60.8) <0.001
HBP [n(%)] 776(43.1) 157(26.9) 284(46.2) 217(52.4) 118(63.4) <0.001
HP history [n(%)] 422(23.5) 57(9.8) 150(24.4) 141(34.1) 74(39.8) <0.001
WHR [Median(P25, P75)] 0.88(0.84,0.92) 0.88(0.84,0.91) 0.88(0.85,0.92) 0.88(0.85,0.92) 0.88(0.84,0.92) 0.118
BMI[Mean(SD), kg/m2] 25.31(3.21) 25.27(3.33) 25.57(3.14) 25.39(3.14) 24.36(2.99) <0.001
Pulse Rate [Mean(SD)] 75.32(8.82) 75.83(8.80) 74.75(9.4) 75.72(8.28) 74.73(7.91) 0.101
Biochemical examination
FBG [Median(P25,P75), mmol/L] 5.4(5.07,5.84) 5.32(5.01,5.70) 5.40(5.08,5.79) 5.46(5.06,6.00) 5.59(5.21,6.21) <0.001
TG [Median(P25,P75), mmol/L] 1.44(1.02,2.01) 1.28(0.92,1.84) 1.51(1.06,2.12) 1.46(1.10,2.05) 1.55(1.14,2.01) <0.001
TC [Mean(SD), mmol/L] 5.05(1.00) 4.86(0.92) 5.09(1.01) 5.16(1.04) 5.20(1.02) <0.001
LDL [Mean(SD), mmol/L] 3.32(0.90) 3.19(0.82) 3.36(0.95) 3.38(0.90) 3.42(0.93) <0.001
HDL [Mean(SD), mmol/L] 1.40(0.31) 1.36(0.30) 1.40(0.30) 1.43(0.32) 1.48(0.34) <0.001
Cognition
MMSE [Median(P25,P75)] 27(24,29) 28(26,29) 27(24,29) 26(23,28) 22(17,25) <0.001
Cognitive impairment [n(%)] 231(12.8) 27(4.6) 88(14.3) 52(12.6) 64(34.4) <0.001

Edu, education; HBP, high blood pressure; HP history, conformed history of hypertension; DM, diabetes mellitus; CHD, coronary heart disease; TIA, transient ischemic attack; CCB, calcium channel blockers; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; WHR, waist-to-hip ratio; BMI, body mass index; FBG, fasting blood glucose; TG, triglycerides; TC, total cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; “-”, lack of a suitable statistical method to test the difference due to the low prevalence.